Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Franzetti

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of the International AIDS Society|November 15, 2014
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimensAndrea Giacomelli, Letizia Oreni, Marco Franzetti, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective StudyGabriele Pagani, Marco Parenti, Marco Franzetti, et al.
BMC Geriatrics|March 11, 2022
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough preventionBarbara Caimi, Marco Franzetti, Rossella Velleca, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 18, 2014
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapyMarco Franzetti, Fulvio Adorni, Letizia Oreni, et al.
BMC Infectious Diseases|July 20, 2014
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in ItalyMarco Franzetti, Michela Violin, Andrea Antinori, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 19, 2020
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case reportMarco Franzetti, Ugo Pozzetti, Manuela Carugati, et al.
Vaccines|March 26, 2022
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care FacilityAlessia Lai, Barbara Caimi, Marco Franzetti, et al.
The New Microbiologica|May 2, 2025
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium speciesFrancesco Bassani, Gabriele Pagani, Marco Franzetti, et al.
Journal of Medical Virology|October 15, 2013
Local and global spatio-temporal dynamics of HIV-1 subtype F1Alessia Lai, Massimo Ciccozzi, Marco Franzetti, et al.
The Journal of General Virology|November 15, 2008
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant formsAndrea Galli, Alessia Lai, Stefano Corvasce, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of the International AIDS Society|November 15, 2014
Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimensAndrea Giacomelli, Letizia Oreni, Marco Franzetti, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Invasive and Non-Invasive Human Salmonellosis Cases Admitted between 2015 and 2021 in Four Suburban Hospitals in the Metropolitan Area of Milan (Italy): A Multi-Center Retrospective StudyGabriele Pagani, Marco Parenti, Marco Franzetti, et al.
BMC Geriatrics|March 11, 2022
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough preventionBarbara Caimi, Marco Franzetti, Rossella Velleca, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 18, 2014
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapyMarco Franzetti, Fulvio Adorni, Letizia Oreni, et al.
BMC Infectious Diseases|July 20, 2014
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in ItalyMarco Franzetti, Michela Violin, Andrea Antinori, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 19, 2020
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case reportMarco Franzetti, Ugo Pozzetti, Manuela Carugati, et al.
Vaccines|March 26, 2022
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care FacilityAlessia Lai, Barbara Caimi, Marco Franzetti, et al.
The New Microbiologica|May 2, 2025
Insidious clinical presentation of uncommon infective endocarditis caused by Cardiobacterium speciesFrancesco Bassani, Gabriele Pagani, Marco Franzetti, et al.
Journal of Medical Virology|October 15, 2013
Local and global spatio-temporal dynamics of HIV-1 subtype F1Alessia Lai, Massimo Ciccozzi, Marco Franzetti, et al.
The Journal of General Virology|November 15, 2008
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant formsAndrea Galli, Alessia Lai, Stefano Corvasce, et al.
Pageof 5